Neos Therapeutics (NEOS) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:NEOS

1.15
-0.03 (-2.54%)
At close: Mar 19, 2021
1.08
-0.07 (-6.09%)
After Hours: 3/19/2021, 8:00:01 PM
Buy % Consensus

100

ChartMill assigns a Buy % Consensus number of 100% to NEOS. The Buy consensus is the weighted average rating of the current analysts ratings.

  • NEOS was analyzed by 1 analysts. The buy percentage consensus is at 100. So analysts seem to be very confident about NEOS.
  • In the previous month the buy percentage consensus was at a similar level.
  • Only 1 analysts analyzed NEOS. So this is just the average opinion of a couple of analysts.

Related screens

NEOS Historical Analyst RatingsNEOS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -26 -24 -22 -20 -18 -16 -14 -12 -10 -8 -6 -4 -2 0 1 2 3 4
NEOS Current Analyst RatingNEOS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.2 0.4 0.6 0.8
Up and Down Grades

Neos Therapeutics / NEOS FAQ

How do analysts rate Neos Therapeutics (NEOS)?

The consensus rating for Neos Therapeutics (NEOS) is 100 / 100 . This indicates that analysts generally have a positive outlook on the stock.


Can you provide the analyst count for Neos Therapeutics stock?

The number of analysts covering Neos Therapeutics (NEOS) is 1.